ELOY DEL
POTRO GÓMEZ
Investigador hasta 2016
Mutua de Terrassa
Terrassa, EspañaPublicaciones en colaboración con investigadores/as de Mutua de Terrassa (1)
2014
-
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: Parallel study of 81 patients
Leukemia and Lymphoma, Vol. 55, Núm. 10, pp. 2341-2348